⌘K
t
MyHealthChecked PLC announced on 14 January 2025 that its phlebotomy test kits have been registered in the UK and EU. These tests, which require a trained phlebotomist, will be an addition to the Company's existing range, with commercialisation targeted for H1 2025.
| Date | 14 Jan 2025 |
| Time | 07:00:07 |
| Category | Miscellaneous |
| ID | 1362T |
MyHealthChecked PLC
("MyHealthChecked" or the "Company")
Phlebotomy tests registered in the UK and EU
MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that the Company's phlebotomy test kits have been registered in the UK and EU. This is a key step in enabling MyHealthChecked to launch and commercialise its phlebotomy service.
The phlebotomy tests will need to be carried out by a trained phlebotomist and MyHealthChecked is looking to commercialise this service in H1 2025. The phlebotomy test kits will be in addition to the Company's existing range of at-home and rapid tests, including DNA and blood sample collection kits.
Penny McCormick, CEO of MyHealthChecked plc, commented: "Registration of our phlebotomy tests in the UK and EU is a great achievement for the team and brings us one step closer to commercialising our phlebotomy tests. We are on track to launch our phlebotomy service in the first half of 2025 and look forward to providing an update to shareholders in due course."
For further information contact:
|
MyHealthChecked plc |
|||
|
Penny McCormick, Chief Executive Officer |
via Walbrook PR |
||
|
|
|
||
|
SPARK Advisory Partners Limited (NOMAD) |
Tel: +44 (0)20 3368 3550 |
||
|
Neil Baldwin / Jade Bayat |
|
||
|
|
|
||
|
Dowgate Capital Limited (Broker) |
Tel: +44 (0)20 3903 7715 |
||
|
David Poutney / Nicholas Chambers |
|
||
|
|
|
||
|
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com |
||
|
Paul McManus / Alice Woodings |
Mob: +44 (0)7980 541 893 / +44(0)7407 804 654 |
||
|
|
|
|
|
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
About Reach announcements
Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.